Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SLCO1B1 protein | affects expression | 20106945
|
C065179 |
atorvastatin |
atorvastatin inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
C065179 |
atorvastatin |
atorvastatin results in decreased activity of SLCO1B1 protein | decreases activity | 15616150
|
D001647 |
Bile Acids and Salts |
SLCO1B1 protein affects the transport of Bile Acids and Salts | affects transport | 15841457
|
D001647 |
Bile Acids and Salts |
SLCO1B1 protein affects the uptake of Bile Acids and Salts | affects uptake | 15841457
|
D001663 |
Bilirubin |
Bilirubin results in increased expression of SLCO1B1 mRNA | increases expression | 15382119
|
D001663 |
Bilirubin |
IL1B protein inhibits the reaction [Bilirubin results in increased expression of SLCO1B1 mRNA] | decreases reaction|increases expression | 15382119
|
D002220 |
Carbamazepine |
Carbamazepine results in increased expression of SLCO1B1 mRNA | increases expression | 17112801
|
D003010 |
Clorgyline |
Clorgyline results in increased expression of SLCO1B1 mRNA | increases expression | 19691856
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SLCO1B1 mRNA | decreases expression | 20106945
|
C025483 |
estradiol-17 beta-glucuronide |
atorvastatin inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
C025483 |
estradiol-17 beta-glucuronide |
Lovastatin inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
C025483 |
estradiol-17 beta-glucuronide |
PKI 166 inhibits the reaction [SLCO1B1 protein affects the transport of estradiol-17 beta-glucuronide] | affects transport|decreases reaction | 15280219
|
C025483 |
estradiol-17 beta-glucuronide |
rifamycin SV inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
C025483 |
estradiol-17 beta-glucuronide |
Simvastatin inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
C025483 |
estradiol-17 beta-glucuronide |
SLCO1B1 protein affects the uptake of estradiol-17 beta-glucuronide | affects uptake | 15652233
|
C025483 |
estradiol-17 beta-glucuronide |
[SLCO1B1 protein co-treated with ABCC2 protein] results in increased uptake of estradiol-17 beta-glucuronide | affects cotreatment|increases uptake | 18180276
|
C025483 |
estradiol-17 beta-glucuronide |
SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide | increases transport | 15616150
|
C017296 |
estrone sulfate |
SLCO1B1 protein affects the uptake of estrone sulfate | affects uptake | 15652233
|
C093230 |
fexofenadine |
[SLCO1B1 protein co-treated with ABCC2 protein] results in increased uptake of fexofenadine | affects cotreatment|increases uptake | 18180276
|
C093230 |
fexofenadine |
SLCO1B1 protein results in increased uptake of fexofenadine | increases uptake | 18245269
|
C065180 |
fluvastatin |
SLCO1B1 protein affects the import of fluvastatin | affects import | 16046661
|
D008148 |
Lovastatin |
Lovastatin inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
D008148 |
Lovastatin |
Lovastatin results in decreased activity of SLCO1B1 protein | decreases activity | 15616150
|
C033457 |
phenobarbital quinidine |
IL1B protein inhibits the reaction [phenobarbital quinidine results in increased expression of SLCO1B1 mRNA] | decreases reaction|increases expression | 15382119
|
C033457 |
phenobarbital quinidine |
phenobarbital quinidine results in increased expression of SLCO1B1 mRNA | increases expression | 15382119
|
C108475 |
pitavastatin |
SLCO1B1 protein affects the transport of pitavastatin | affects transport | 15955871
|
C410026 |
PKI 166 |
PKI 166 inhibits the reaction [SLCO1B1 protein affects the transport of estradiol-17 beta-glucuronide] | affects transport|decreases reaction | 15280219
|
C410026 |
PKI 166 |
PKI 166 results in decreased activity of SLCO1B1 protein | decreases activity | 15280219
|
C410026 |
PKI 166 |
SLCO1B1 protein affects the transport of PKI 166 metabolite | affects transport | 15280219
|
C072379 |
repaglinide |
SLCO1B1 gene SNP affects the metabolism of repaglinide | affects metabolic processing | 15961978
|
D012293 |
Rifampin |
Rifampin results in increased expression of SLCO1B1 mRNA | increases expression | 15670600 16837569
|
D012293 |
Rifampin |
SLCO1B1 protein affects the uptake of Rifampin | affects uptake | 15652233
|
C023808 |
rifamycin SV |
rifamycin SV inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
C023808 |
rifamycin SV |
rifamycin SV results in decreased activity of SLCO1B1 protein | decreases activity | 15616150
|
D019821 |
Simvastatin |
Simvastatin inhibits the reaction [SLCO1B1 protein results in increased transport of estradiol-17 beta-glucuronide] | decreases reaction|increases transport | 15616150
|
D019821 |
Simvastatin |
Simvastatin results in decreased activity of SLCO1B1 protein | decreases activity | 15616150
|
D013448 |
Sulfobromophthalein |
SLCO1B1 protein affects the import of Sulfobromophthalein | affects import | 16046661
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
4.46 | 8986270 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
fexofenadine |
5.68 | 16037679 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
4.09 | 17594078 20046352 |
MESH:D001943 |
Breast Neoplasms |
|
estrone sulfate |
4.52 | 17261762 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.95 | 21507988 12619106 12907637 |
MESH:D006332 |
Cardiomegaly |
|
atorvastatin |
4.38 | 18360054 |
MESH:D002386 |
Cataract |
|
Simvastatin |
4.58 | 12518039 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.47 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.54 | 19486331 |
MESH:D002779 |
Cholestasis |
|
estradiol-17 beta-glucuronide |
8.54 | 12893835 |
MESH:D003324 |
Coronary Artery Disease |
|
atorvastatin |
4.11 | 16368305 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.75 | 16142594 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
2.95 | 9014606 |
MESH:D003550 |
Cystic Fibrosis |
|
Simvastatin |
4.86 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
fexofenadine |
4.73 | 17133778 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.36 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.35 | 16538176 20216337 16538175 15057820 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
3.21 | 17465707 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
4.39 | 20216337 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
4.65 | 17654737 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.17 | 19915237 18855540 16538176 16415921 20485159 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
5.12 | 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
4.89 | 17116037 16628512 15008574 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
3.95 | 821787 17178248 19439326 20417680 19700373 17465707 7988514 9014606 19620853 18234410 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
5.27 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
5.04 | 3659116 15276670 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.64 | 19549232 |
MESH:D004942 |
Esophagitis, Peptic |
|
Bile Acids and Salts |
6.47 | 11346197 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.38 | 20485159 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.77 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.06 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
MESH:D006333 |
Heart Failure |
|
atorvastatin |
8.21 | 16360360 |
MESH:D006333 |
Heart Failure |
|
pitavastatin |
8.21 | 15502390 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
MESH:D006937 |
Hypercholesterolemia |
|
atorvastatin |
4.99 | 11583720 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.65 | 10459572 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
atorvastatin |
10.18 | 16238680 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
Simvastatin |
10.18 | 16238680 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.12 | 18773962 |
MESH:D006967 |
Hypersensitivity |
|
fexofenadine |
5.25 | 17910814 |
MESH:D006973 |
Hypertension |
|
atorvastatin |
5.59 | 17042910 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.59 | 10903974 |
MESH:D007249 |
Inflammation |
|
atorvastatin |
3.87 | 16908763 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.29 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.66 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
atorvastatin |
3.29 | 17347453 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
2.32 | 15890375 9163691 18177683 2125692 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.69 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
1.87 | 14755239 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Rifampin |
6.04 | 11422169 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
6.07 | 16628512 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Rifampin |
6.07 | 11422169 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.70 | 9014606 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
4.46 | 16996129 |
MESH:D009135 |
Muscular Diseases |
|
atorvastatin |
5.38 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
Rifampin |
5.47 | 18474467 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.38 | 20399394 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
atorvastatin |
9.46 | 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.46 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
4.82 | 16990009 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
5.38 | 17016548 |
MESH:D010146 |
Pain |
|
Carbamazepine |
3.96 | 15215642 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.61 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.84 | 17145499 17679678 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Simvastatin |
5.27 | 17105841 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.06 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
4.80 | 9014606 |
MESH:D011471 |
Prostatic Neoplasms |
|
Clorgyline |
4.31 | 19691856 |
MESH:D011537 |
Pruritus |
|
fexofenadine |
5.53 | 17133778 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
5.52 | 9591791 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
3.74 | 16876388 19414003 9844417 15946322 9046859 16938433 16180713 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.04 | 19414003 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.12 | 20485159 15057820 16415921 16538176 19694795 19915237 18855540 |
MESH:D014376 |
Tuberculosis |
|
Rifampin |
4.71 | 15236969 18397238 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |